Bi-Yun Wang

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 279 citations

First-line Therapy, Breast Oncology, Oncology +7

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Bi-Yun Wang, Jian Zhang, Jia-Lei Wang et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 177 citations · Full text

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

Xin Liu, Xiaonan Hong, Ya-Jia Gu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 69 citations

Lymphoid Neoplasia, Rituximab-containing Chemotherapy, Medicine +11

The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer

Jian Zhang, Joseph Ragaz, Ying-Jian Zhang et al. · BMC Cancer · 2013 · 32 citations · Full text

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells

Lei-Ping Wang, Jun Cao, Jian Zhang et al. · Medical Oncology · 2015 · 22 citations

Tumor Biology, Signal Transduction, Signaling Pathway +9